Items per page
Sort by

Send to:

Choose Destination

Links from PubMed

Items: 1 to 20 of 129


Structural and functional studies of trans-encoded HLA-DQ2.3 (DQA1*03:01/DQB1*02:01) protein molecule.

Tollefsen S, Hotta K, Chen X, Simonsen B, Swaminathan K, Mathews II, Sollid LM, Kim CY.

J Biol Chem. 2012 Apr 20;287(17):13611-9. doi: 10.1074/jbc.M111.320374. Epub 2012 Feb 23.


HLA-DQ2 and -DQ8 signatures of gluten T cell epitopes in celiac disease.

Tollefsen S, Arentz-Hansen H, Fleckenstein B, Molberg O, Ráki M, Kwok WW, Jung G, Lundin KE, Sollid LM.

J Clin Invest. 2006 Aug;116(8):2226-36. Epub 2006 Jul 27.


Gluten-specific T cells cross-react between HLA-DQ8 and the HLA-DQ2α/DQ8β transdimer.

Kooy-Winkelaar Y, van Lummel M, Moustakas AK, Schweizer J, Mearin ML, Mulder CJ, Roep BO, Drijfhout JW, Papadopoulos GK, van Bergen J, Koning F.

J Immunol. 2011 Nov 15;187(10):5123-9. doi: 10.4049/jimmunol.1101179. Epub 2011 Oct 17.


T-cell response to gluten in patients with HLA-DQ2.2 reveals requirement of peptide-MHC stability in celiac disease.

Bodd M, Kim CY, Lundin KE, Sollid LM.

Gastroenterology. 2012 Mar;142(3):552-61. doi: 10.1053/j.gastro.2011.11.021. Epub 2011 Nov 19.


Modelling of HLA-DQ2 and its interaction with gluten peptides to explain molecular recognition in celiac disease.

Costantini S, Rossi M, Colonna G, Facchiano AM.

J Mol Graph Model. 2005 Apr;23(5):419-31. Epub 2005 Jan 18.


Structure of celiac disease-associated HLA-DQ8 and non-associated HLA-DQ9 alleles in complex with two disease-specific epitopes.

Moustakas AK, van de Wal Y, Routsias J, Kooy YM, van Veelen P, Drijfhout JW, Koning F, Papadopoulos GK.

Int Immunol. 2000 Aug;12(8):1157-66.


Main chain hydrogen bond interactions in the binding of proline-rich gluten peptides to the celiac disease-associated HLA-DQ2 molecule.

Bergseng E, Xia J, Kim CY, Khosla C, Sollid LM.

J Biol Chem. 2005 Jun 10;280(23):21791-6. Epub 2005 Apr 12.


Structural basis for HLA-DQ2-mediated presentation of gluten epitopes in celiac disease.

Kim CY, Quarsten H, Bergseng E, Khosla C, Sollid LM.

Proc Natl Acad Sci U S A. 2004 Mar 23;101(12):4175-9. Epub 2004 Mar 12.


The production and crystallization of the human leukocyte antigen class II molecules HLA-DQ2 and HLA-DQ8 complexed with deamidated gliadin peptides implicated in coeliac disease.

Henderson KN, Reid HH, Borg NA, Broughton SE, Huyton T, Anderson RP, McCluskey J, Rossjohn J.

Acta Crystallogr Sect F Struct Biol Cryst Commun. 2007 Dec 1;63(Pt 12):1021-5. Epub 2007 Nov 21.


Type 1 diabetes-associated HLA-DQ8 transdimer accommodates a unique peptide repertoire.

van Lummel M, van Veelen PA, Zaldumbide A, de Ru A, Janssen GM, Moustakas AK, Papadopoulos GK, Drijfhout JW, Roep BO, Koning F.

J Biol Chem. 2012 Mar 16;287(12):9514-24. doi: 10.1074/jbc.M111.313940. Epub 2011 Dec 19.


HLA-DQ molecules as affinity matrix for identification of gluten T cell epitopes.

Dørum S, Bodd M, Fallang LE, Bergseng E, Christophersen A, Johannesen MK, Qiao SW, Stamnaes J, de Souza GA, Sollid LM.

J Immunol. 2014 Nov 1;193(9):4497-506. doi: 10.4049/jimmunol.1301466. Epub 2014 Sep 26.


Resistance to celiac disease in humanized HLA-DR3-DQ2-transgenic mice expressing specific anti-gliadin CD4+ T cells.

de Kauwe AL, Chen Z, Anderson RP, Keech CL, Price JD, Wijburg O, Jackson DC, Ladhams J, Allison J, McCluskey J.

J Immunol. 2009 Jun 15;182(12):7440-50. doi: 10.4049/jimmunol.0900233.


The HLA-DQ2 gene dose effect in celiac disease is directly related to the magnitude and breadth of gluten-specific T cell responses.

Vader W, Stepniak D, Kooy Y, Mearin L, Thompson A, van Rood JJ, Spaenij L, Koning F.

Proc Natl Acad Sci U S A. 2003 Oct 14;100(21):12390-5. Epub 2003 Oct 6.


HLA types in celiac disease patients not carrying the DQA1*05-DQB1*02 (DQ2) heterodimer: results from the European Genetics Cluster on Celiac Disease.

Karell K, Louka AS, Moodie SJ, Ascher H, Clot F, Greco L, Ciclitira PJ, Sollid LM, Partanen J; European Genetics Cluster on Celiac Disease.

Hum Immunol. 2003 Apr;64(4):469-77.


Human leukocyte antigen DQ2.2 and celiac disease.

Mubarak A, Spierings E, Wolters V, van Hoogstraten I, Kneepkens CM, Houwen R.

J Pediatr Gastroenterol Nutr. 2013 Apr;56(4):428-30. doi: 10.1097/MPG.0b013e31827913f9.


Impaired binding of a DQ2 and DQ8-binding HSV VP16 peptide to a DQA1*0501/DQB1*0302 trans class II heterodimer.

Reichstetter S, Kwok WW, Nepom GT.

Tissue Antigens. 1999 Jan;53(1):101-5.


Different binding motifs of the celiac disease-associated HLA molecules DQ2.5, DQ2.2, and DQ7.5 revealed by relative quantitative proteomics of endogenous peptide repertoires.

Bergseng E, Dørum S, Arntzen MØ, Nielsen M, Nygård S, Buus S, de Souza GA, Sollid LM.

Immunogenetics. 2015 Feb;67(2):73-84. doi: 10.1007/s00251-014-0819-9. Epub 2014 Dec 12.


Staining of celiac disease-relevant T cells by peptide-DQ2 multimers.

Quarsten H, McAdam SN, Jensen T, Arentz-Hansen H, Molberg Ø, Lundin KE, Sollid LM.

J Immunol. 2001 Nov 1;167(9):4861-8.

Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk